Myasthenia gravis--treatment of acute severe exacerbations in the intensive care unit results in a favourable long-term prognosis. (2014)

First Author: Spillane J
Attributed to:  Gene therapy for refractory epilepsy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/ene.12115

PubMed Identifier: 23398500

Publication URI: http://europepmc.org/abstract/MED/23398500

Type: Journal Article/Review

Volume: 21

Parent Publication: European journal of neurology

Issue: 1

ISSN: 1351-5101